IBC Membership Information

---

The Institutional Biosafety Committee (IBC) is composed of no fewer than five members whose responsibility is to review, approve, and oversee all teaching and research projects involving recombinant or synthetic nucleic acid molecules and other biohazardous material. Members are selected so that collectively they have the experience and expertise to review protocols and assess potential risk to people, animals, and plants. The IBC meets no less frequently than quarterly and normally, bimonthly. No official business may be conducted without a quorum of the current voting membership. Certain low-risk activities may be reviewed by a subset of the IBC and approved.

 

Any change in organisms, project scope, methodology, or project personnel must be pre-approved by the IBC before the changes are implemented. The Office of University Research Compliance maintains records of protocols, minutes of meetings, laboratory inspection reports, and other documentation relevant to IBC business. No member of an IBC may be involved (except to provide information requested by the IBC) in the review or approval of a project in which he/she expects to be engaged or has a financial interest.

 

Coordination with Other University Research Compliance Committees

Depending on the specific activity, an investigator may be required to seek prior or concurrent approval(s) from other compliance committees, to include the, Institutional Animal Care and Use Committee (IACUC), the Institutional Review Board (IRB), the Radiation Safety Committee, and/or the Laser Safety Committee.